BioCardia, Inc. will provide a corporate update and report financial results for the three months ended June 30, 2025 via conference call on August 11, 2025 at 4:30 PM ET. Interested participants can register for the call and receive the dial-in number at https://dpregister.com/sreg/10201553/ff96e5f036. Registered participants should dial in 10 minutes prior to the start time. The call will also be available through a live webcast. BioCardia is a global leader in cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with three clinical stage product candidates in development. Visit www.biocardia.com for more information.

Read more at 1. “Apple unveils new iPhone 13 models with improved cameras and longer battery life.” – Reuters

2. “Tesla announces plans to build a new Gigafactory in Texas, creating thousands of jobs.” – CNBC

3. “Amazon reports record-breaking sales during Prime Day, surpassing $10 billion in revenue.” – Wall Street Journal

4. “Federal Reserve announces plans to raise interest rates in response to inflation concerns.” – CBS MarketWatch

5. “Facebook faces backlash over leaked documents revealing internal knowledge of harms caused by platform.” – Barchart: BioCardia to Host Q2 2025 Corporate Update and Financial